These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2931 related articles for article (PubMed ID: 32720259)

  • 1. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.
    Montero F; Martínez-Barrio J; Serrano-Benavente B; González T; Rivera J; Molina Collada J; Castrejón I; Álvaro-Gracia J
    Rheumatol Int; 2020 Oct; 40(10):1593-1598. PubMed ID: 32794113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
    Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
    Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
    Freites Nuñez DD; Leon L; Mucientes A; Rodriguez-Rodriguez L; Font Urgelles J; Madrid García A; Colomer JI; Jover JA; Fernandez-Gutierrez B; Abasolo L
    Ann Rheum Dis; 2020 Nov; 79(11):1393-1399. PubMed ID: 32769150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
    Santos CS; Férnandez XC; Moriano Morales C; Álvarez ED; Álvarez Castro C; López Robles A; Pérez Sandoval T
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33455920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.
    Ferrando C; Mellado-Artigas R; Gea A; Arruti E; Aldecoa C; Bordell A; Adalia R; Zattera L; Ramasco F; Monedero P; Maseda E; Martínez A; Tamayo G; Mercadal J; Muñoz G; Jacas A; Ángeles G; Castro P; Hernández-Tejero M; Fernandez J; Gómez-Rojo M; Candela Á; Ripollés J; Nieto A; Bassas E; Deiros C; Margarit A; Redondo FJ; Martín A; García N; Casas P; Morcillo C; Hernández-Sanz ML;
    Rev Esp Anestesiol Reanim (Engl Ed); 2020 Oct; 67(8):425-437. PubMed ID: 32800622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2.
    Elamari S; Motaib I; Zbiri S; Elaidaoui K; Chadli A; Elkettani C
    Pan Afr Med J; 2020; 37():32. PubMed ID: 33209159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Mortality in Adults Admitted with COVID-19: Retrospective Cohort Study from New York City.
    Chilimuri S; Sun H; Alemam A; Mantri N; Shehi E; Tejada J; Yugay A; Nayudu SK
    West J Emerg Med; 2020 Jul; 21(4):779-784. PubMed ID: 32726241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.
    Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G
    Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics, complications and outcomes among 1549 patients hospitalised with COVID-19 in a secondary hospital in Madrid, Spain: a retrospective case series study.
    Jiménez E; Fontán-Vela M; Valencia J; Fernandez-Jimenez I; Álvaro-Alonso EA; Izquierdo-García E; Lazaro Cebas A; Gallego Ruiz-Elvira E; Troya J; Tebar-Martinez AJ; Garcia-Marina B; Peña-Lillo G; Abad-Motos A; Macaya L; Ryan P; Pérez-Butragueño M; ;
    BMJ Open; 2020 Nov; 10(11):e042398. PubMed ID: 33172949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality.
    Fernández-Cruz A; Ruiz-Antorán B; Muñoz-Gómez A; Sancho-López A; Mills-Sánchez P; Centeno-Soto GA; Blanco-Alonso S; Javaloyes-Garachana L; Galán-Gómez A; Valencia-Alijo Á; Gómez-Irusta J; Payares-Herrera C; Morrás-Torre I; Sánchez-Chica E; Delgado-Téllez-de-Cepeda L; Callejas-Díaz A; Ramos-Martínez A; Múñez-Rubio E; Avendaño-Solá C
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study.
    Moreno-Pérez O; Andres M; Leon-Ramirez JM; Sánchez-Payá J; Rodríguez JC; Sánchez R; García-Sevila R; Boix V; Gil J; Merino E
    J Autoimmun; 2020 Nov; 114():102523. PubMed ID: 32690352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
    Gianfrancesco M; Hyrich KL; Al-Adely S; Carmona L; Danila MI; Gossec L; Izadi Z; Jacobsohn L; Katz P; Lawson-Tovey S; Mateus EF; Rush S; Schmajuk G; Simard J; Strangfeld A; Trupin L; Wysham KD; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Yazdany J; Machado PM; Robinson PC;
    Ann Rheum Dis; 2020 Jul; 79(7):859-866. PubMed ID: 32471903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.
    Bonetti G; Manelli F; Patroni A; Bettinardi A; Borrelli G; Fiordalisi G; Marino A; Menolfi A; Saggini S; Volpi R; Anesi A; Lippi G
    Clin Chem Lab Med; 2020 Jun; 58(7):1100-1105. PubMed ID: 32573995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations.
    Marzolini C; Stader F; Stoeckle M; Franzeck F; Egli A; Bassetti S; Hollinger A; Osthoff M; Weisser M; Gebhard CE; Baettig V; Geenen J; Khanna N; Tschudin-Sutter S; Mueller D; Hirsch HH; Battegay M; Sendi P
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32641296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study.
    Della-Torre E; Campochiaro C; Cavalli G; De Luca G; Napolitano A; La Marca S; Boffini N; Da Prat V; Di Terlizzi G; Lanzillotta M; Rovere Querini P; Ruggeri A; Landoni G; Tresoldi M; Ciceri F; Zangrillo A; De Cobelli F; Dagna L; ;
    Ann Rheum Dis; 2020 Oct; 79(10):1277-1285. PubMed ID: 32620597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy.
    Ciceri F; Castagna A; Rovere-Querini P; De Cobelli F; Ruggeri A; Galli L; Conte C; De Lorenzo R; Poli A; Ambrosio A; Signorelli C; Bossi E; Fazio M; Tresoldi C; Colombo S; Monti G; Fominskiy E; Franchini S; Spessot M; Martinenghi C; Carlucci M; Beretta L; Scandroglio AM; Clementi M; Locatelli M; Tresoldi M; Scarpellini P; Martino G; Bosi E; Dagna L; Lazzarin A; Landoni G; Zangrillo A
    Clin Immunol; 2020 Aug; 217():108509. PubMed ID: 32535188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
    Wang Z; Wang Z
    BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of COVID-19 patients in three consecutive generations of spread in Zhejiang, China.
    Yao Y; Chen W; Wu X; Shen L; Shen L; Fu Y; Yang Q; Yao M; Zhou J; Zhou H
    Clin Microbiol Infect; 2020 Oct; 26(10):1380-1385. PubMed ID: 32593742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 147.